Abstract: The present disclosure relates to a device for limiting movement of a movable part in electrical equipment and the electrical equipment including the same. The limiting device includes: a stopper provided in a moving path of the movable part and configured to contact the movable part at a predetermined position to prevent the movable part from moving; wherein the stopper is mainly formed of an elastomer and includes a stop surface, the elastomer being configured to be deformed when the movable part collides with the stop surface in a first direction; and wherein the elastomer further includes holes. With the holes being provided in the elastomer, impact resistance of the elastomer is enhanced, and performance deterioration of the elastomer due to a temperature rise is compensated.

Abstract: A modular contactor. The modular contactor includes a driving module (1), an intermediate connection module (2), a breaking module (3), an upper application interface module (4), and a lower application interface module (5); the driving module (1) is detachably connected to a first side of the intermediate connection module (2); the breaking module (3) is detachably connected to a second side of the intermediate connection module (2) ; the upper application interface module (4) is detachably connected to the top of the breaking module (3) so as to be electrically connected to upper static contacts of the multiple breaking units; the lower application interface module (5) is detachably connected to the bottom of the breaking module (3) so as to be electrically connected to lower static contacts of the multiple breaking units.

Abstract: The disclosure provides a feature compression algorithm based on neural network, including the following steps: S1, image data preparation: collecting facial images, and uniformly performing map processing to the facial images collected; S2, feature data acquisition: delivering the facial images processed into a face recognition system for face detection and feature extraction, and saving facial feature data; S3, setting up a neural network model; S4, model iteration training; S5, storing a parameter model; and S6, feature compression. The feature compression algorithm based on neural network of the disclosure can not only achieve compression of original feature data, but also retain its original semantic feature, which belongs to a higher-dimensional feature abstraction. The compressed feature data can be directly used.

Abstract: The disclosure provides a feature compression algorithm based on neural network, including the following steps: S1, image data preparation: collecting facial images, and uniformly performing map processing to the facial images collected; S2, feature data acquisition: delivering the facial images processed into a face recognition system for face detection and feature extraction, and saving facial feature data; S3, setting up a neural network model; S4, model iteration training; S5, storing a parameter model; and S6, feature compression. The feature compression algorithm based on neural network of the disclosure can not only achieve compression of original feature data, but also retain its original semantic feature, which belongs to a higher-dimensional feature abstraction. The compressed feature data can be directly used.

Abstract: This relates to the pharmaceutical use of KOH, in forms of topical, oral drugs or intravenous drip, prepared for treating high blood uric acid, especially gout. The external application refers to footbath in soaking solution or embrocation on attack position. The action of the drugs is also to promote the excretion of uric acid. Compared with colchicine and other drugs, KOH has three notable features. First, it takes effect quickly. No matter being applied by footbath, oral or embrocation, it can relieve symptoms within ten minutes, and the pain during gout attack will be significantly reduced. Second, it takes curative effect quickly. After application of the drugs for 2-3 consecutive days, gout symptoms will completely disappear. Third, it has no side effects. In one respect, with a low concentration, the KOH will not corrode the skin. In a further respect, potassium ion itself is diuretic and it has no harm to kidney.

Abstract: This relates to the pharmaceutical use of KOH, in forms of topical, oral drugs or intravenous drip, prepared for treating high blood uric acid, especially gout. The external application refers to footbath in soaking solution or embrocation on attack position. The action of the drugs is also to promote the excretion of uric acid. Compared with colchicine and other drugs, KOH has three notable features. First, it takes effect quickly. No matter being applied by footbath, oral or embrocation, it can relieve symptoms within ten minutes, and the pain during gout attack will be significantly reduced. Second, it takes curative effect quickly. After application of the drugs for 2-3 consecutive days, gout symptoms will completely disappear. Third, it has no side effects. In one respect, with a low concentration, the KOH will not corrode the skin. In a further respect, potassium ion itself is diuretic and it has no harm to kidney.